TWC
HAE icon

TD Waterhouse Canada’s Haemonetics HAE Stock Holding History

TD Waterhouse Canada’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.5K Hold
314
– – ﹤0.01% 1613
2026
Q1 		$17.6K Hold
314
– – ﹤0.01% 1617
2025
Q4 		$25.2K Hold
314
– – ﹤0.01% 1347
2025
Q3 		$15.3K Sell
314
-50
-14% -$3.1K ﹤0.01% 1454
2025
Q2 		$27.8K Buy
364
+50
+16% +$3.31K ﹤0.01% 1255
2025
Q1 		$19.8K Hold
314
– – ﹤0.01% 1269
2024
Q4 		$24.5K Buy
+314
New +$25.2K ﹤0.01% 1235

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

TD Waterhouse Canada's HAE Position: Q2 2026 in Review

TD Waterhouse Canada held its Haemonetics (HAE) position steady in Q2 2026 at 314 shares worth $23.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1613.

TD Waterhouse Canada first reported a position in HAE in Q4 2024 and has held it in 7 quarters since. The position peaked at $27.8K in Q2 2025. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • TD Waterhouse Canada held 314 shares of Haemonetics worth $23.5K as of Q2 2026.
  • TD Waterhouse Canada left its Haemonetics share count unchanged in Q2 2026.
  • Haemonetics made up ﹤0.01% of TD Waterhouse Canada's portfolio in Q2 2026, its #1613 holding.
  • TD Waterhouse Canada first reported a position in Haemonetics in Q4 2024 and has held it in 7 quarters since.
  • TD Waterhouse Canada's Haemonetics position peaked at $27.8K in Q2 2025.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.